Clinical Trial Update: Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating tolerance induction in relapsing-remitting multiple sclerosis using autologous peptide-coupled peripheral blood mononuclear cells; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Peptide-Coupled Peripheral Blood Mononuclear Cells (Autologous peptide-coupled peripheral blood mononuclear cells)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-08